Detalhe da pesquisa
1.
A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.
J Surg Res
; 228: 54-62, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29907230
2.
Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.
Bioorg Med Chem
; 22(1): 178-85, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24359708
3.
Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).
Mol Pharmacol
; 83(3): 698-708, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23292798
4.
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats.
Cancers (Basel)
; 15(3)2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765604
5.
Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.
J Med Chem
; 65(21): 14409-14423, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36318154
6.
Effects of High-Fructose Diet vs. Teklad Diet in the MNU-Induced Rat Mammary Cancer Model: Altered Tumorigenesis, Metabolomics and Tumor RNA Expression.
J Obes Chronic Dis
; 5(1): 67-78, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33834161
7.
Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy.
J Urol
; 183(4): 1598-603, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20172542
8.
Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically Induced Cancers.
Cancer Prev Res (Phila)
; 13(3): 283-290, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31871222
9.
Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers.
Cancer Prev Res (Phila)
; 13(3): 273-282, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818850
10.
High Cks1 expression in transgenic and carcinogen-initiated mammary tumors is not always accompanied by reduction in p27Kip1.
Int J Oncol
; 34(5): 1425-31, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19360356
11.
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.
Mol Cancer Ther
; 7(4): 972-9, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18375820
12.
Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors.
Metabolites
; 9(7)2019 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31336604
13.
[Corrigendum] Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models.
Oncol Rep
; 41(1): 718, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365076
14.
Evaluation of the STAT3 inhibitor GLG302 for the prevention of estrogen receptorpositive and negative mammary cancers.
Oncol Rep
; 42(3): 1205-1213, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31322250
15.
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers.
Cancer Prev Res (Phila)
; 12(12): 903-912, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484659
16.
Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
Int J Cancer
; 123(10): 2254-9, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18712722
17.
Effect of cranberry juice concentrate on chemically-induced urinary bladder cancers.
Oncol Rep
; 19(6): 1565-70, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18497966
18.
Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.
Clin Cancer Res
; 13(18 Pt 1): 5488-96, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875779
19.
Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols.
Mol Cancer Ther
; 6(7): 2022-8, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17620432
20.
Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression.
Cancer Prev Res (Phila)
; 11(10): 595-606, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045934